• Share
  • Email
  • Print

Jeffrey W. Acre

Partner
+1.412.355.6506
Fax +1.412.355.6501
Mr. Acre maintains a corporate practice focusing on securities law matters, various financing transactions and mergers and acquisition transactions. Mr. Acre has experience in representing publicly-traded and privately-held clients in a variety of stock and asset transactions and financing arrangements. Mr. Acre's practice also encompasses public and private securities offerings, as well as securities law and stock exchange compliance issues. In addition, Mr. Acre's corporate practice includes counseling corporations regarding structuring and general corporate matters, including corporate governance obligations.

Speaking Engagements

  • Speaker, Mylan Pharmaceuticals Inc. Continuing Legal Education Series, Corporate/SEC seminar (May 2003)
  • Provides general corporate and securities law advice to publicly held companies on a broad range of issues.
  • Represented several public companies in filing universal shelf registration statements and other registration statements.
  • Represented a public company in an underwritten public offering of two tranches of senior notes in the aggregate principal amount of €900.0 million.
  • Represented a public company in a $750.0 million Rule 144A offering of senior notes.
  • Represented a public company in a $287.5 million underwritten public offering of convertible senior notes.
  • Represented a public company in an underwritten public offering of two tranches of senior notes in the aggregate principal amount of €1.2 billion.
  • Represented a public company in a modified Dutch auction tender offer for up to $175.0 million of its outstanding ordinary shares.
  • Represented a public company in a $300.0 million underwritten public offering of senior notes and a related $450.0 million issuer tender offer for two series of its outstanding senior notes and redemption of an aggregate of $1.4 billion of outstanding debt securities.
  • Represented a public company in a $350.0 million Rule 144A offering of senior secured second lien notes and a related $600.0 million issuer tender offer for and redemption of a series of its outstanding senior notes.
  • Represented a public company in a $250.0 million underwritten public offering of senior notes.
  • Represented a public company in a $500.0 million underwritten public offering of senior notes.
  • Represented a public company in a $375.0 million Rule 144A offering of senior notes and a related registered exchange offer.